392

Medical Retina
6th ESASO Module 2018

Medical Retina
6th ESASO Module 2018

Datum
09.04.2018, 08:30 - 13.04.2018, 13:00
Lehrkurs
Lugano-Viganello
Sprache
Englisch
Gebühren ab
gebührenfrei
Veranstalter
European School for Advanced Studies in Ophthalmology ESASO
c/o Università della Svizzera italiana (USI)
Organisator

European School for Advanced Studies in Ophthalmology ESASO
c/o Università della Svizzera italiana (USI)
Via G. Buffi 13
CH - 6904 Lugano
Tel.: +41 (0)58 666 46 29
Fax: +41 (0)58 666 46 19

This sixth module of the ESASO training courses in 2018 will focus on medical retina. International speakers will share their knowledge. The training course will take place in Lugano, Switzerland.
  • Basisinformation
    Datum
    09.04.2018, 08:30 - 13.04.2018, 13:00
    Lehrkurs
    Lugano-Viganello
    Sprache
    Englisch
    Gebühren ab
    gebührenfrei
    Veranstalter
    European School for Advanced Studies in Ophthalmology ESASO
    c/o Università della Svizzera italiana (USI)
    Organisator

    European School for Advanced Studies in Ophthalmology ESASO
    c/o Università della Svizzera italiana (USI)
    Via G. Buffi 13
    CH - 6904 Lugano
    Tel.: +41 (0)58 666 46 29
    Fax: +41 (0)58 666 46 19

  • VERANSTALTUNGSORT
    Ospedale Italiano di Lugano
    Via Pietro Capelli 1
    6962 Lugano-Viganello, CH
  • Programm
        Monday, 9 April 2018 
    08:30   Registration and welcoming
               
        AMD AND MORE: WHAT THE IMAGING TELL
    09:00   The normal and the pathologic in imaging (SW and NIR Autofluorescence, Fluorescein Angiography, sd OCT, OCT-A)
    09:45   Pearls, tips and pitfalls in reading and correlating diagnostic imaging
    10:30   COFFEE BREAK
    11:00   Multimodal imaging of dry AMD – diagnosis and progression
    11:30   Best monitoring with imaging of an AMD at neovascular risk
    12:00   Differential diagnosis and prognostic characteristics of neovascular forms in AMD
    12:30   Imaging the management of nAMD
    13:00   LUNCH
    14:00   Imaging early and late non-responders in AMD
    14:30   The imaging aspects of the end of treatment
    15:00   COFFEE BREAK
    15:30   Multimodal imaging of dystrophies or macular telangiectasia mimicking AMD
    16:00-16:30   Diagnosis and monitoring a myopic choroidal neovascularisation
               
               
        Tuesday, 10 April 2018 
        AMD AND MORE: CLINIC 
    08:30   Dry AMD efficacy of treatment: none, support or really treatment?
    09:15   Anti-VEGF Treatment regimens for neovascular AMD
    10:00   Real World Outcomes of Anti-VEGF therapy for neovascular AMD
    10:45   COFFEE BREAK
    11:15   Anti-VEGF treatment regimens for myopic choroidal neovascularisation and Long-term outcomes
    12:00   Cases study of management and monitoring of neovascular AMD
    13:00   LUNCH
    14:00   Cases study of management and monitoring of PCV
    14:45   Cases study of management and monitoring of myopic choroidal neovascularisation
    15:30   COFFEE BREAK
    16:00   Cases study of management and monitoring of RAP
    16:45-17:15   Cases study of management and monitoring of other CNV
               
               
        Wednesday, 11 April 2018 
        A TECHNICAL INSIGHT OF INTRAVITREAL TREATMENT
    08:30-12:30    Industry Satellite Symposia
    12:45   LUNCH
               
        ONCOLOGY COURSE: POSTERIOR SEGMENT TUMORS
    13:45   Diagnosis and management of retinoblastoma and uveal melanoma
    15:15   COFFEE BREAK
    15:45   Vascular tumours, differential diagnosis, and treatment
    16:45-17:15   Practical cases in ocular oncology
               
               
        Thursday, 12 April 2018 
        DR AND RVO
    08:30   Safety of intravitreal treatments 
    09:15   Differences in efficacy among the intravitreal treatments for DME
    09:45   Regimens of treatment and criteria for dealing with poor responders, optimize the results, and lower the burden of treatment
    10:30   COFFEE BREAK
    11:00   Real life data of DME intravitreal treatments and patients management
    11:30   PDR treatment with anti-VEGF: beyond protocol results what is his clinical application?
    12:00   Intravitreal steroids and anti-VEGF treatment of ME in RVO
    12:45   LUNCH
    13:45   Cases study of management and monitoring of DME
    14:30   Cases study of management and monitoring of ME in RVO
    15:15   Cases study of management and monitoring of PDR
    16:00-16:45   Cases study of management and monitoring of other vascular retinopathies (Von-Hipple, Leber-Coats etc.)
               
               
        Friday, 13 April 2018 
        MICROPULSE LASER COURSE
    08:30   Subvisible-threshold retinal laser treatments with micropulse lasers: physical principles and guidelines for settingthe laser parameters
    09:30   Subvisible-threshold retinal laser treatments with micropulse lasers: evidence from prospective randomized controlled clinical trials in the treatment of DME, RVO-ME, and CSC
    10:00   COFFEE BREAK
    10:30   Clinical cases review and study of treatment of various retinovascular disorders
    11:30   New frontiers in the use of micropulse lasers in the treatment of chronic, progressive and degenerative retinal disorders of disparate etiology and pathogenesis
    12:15-13:00   Test, certificates and farewell
  • Gebühren
    Fachärzte/-innen
    Gebühren ab
    gebührenfrei
    Ärzte/-innen in Weiterbildung
    Gebühren ab
    gebührenfrei
  • Buchung / Anmeldung

     

    Please contact the organizer for further information.

  • Zertifizierung
    Keine Zertifizierung beantragt

Veranstaltung teilen